Clinical Cancer Research Journal Issues Research Articles in Nov. 1, 2021 Edition
November 01, 2021
November 01, 2021
PHILADELPHIA, Pennsylvania, Nov. 1 -- Clinical Cancer Research, a journal from the American Association for Cancer Research that presents clinical and translational cancer research studies that bridge the laboratory and the clinic, published research articles, including the following topics, in its Nov. 1, 2021 edition:
Targeted Therapy:
* Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, Monotherapy in Patients . . .
Targeted Therapy:
* Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, Monotherapy in Patients . . .